Alnylam Pharmaceuticals
ALNY
#1108
Rank
S$27.51 B
Marketcap
S$205.43
Share price
5.41%
Change (1 day)
-65.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company